Type 2 Diabetes Coverage Most insurance plans cover Ozempic when prescribed for type 2 diabetes management, its FDA-approved indication
Why use the combination
It is particularly well suited for patients with a BMI of 35 or greater, or significant obesity-related metabolic conditions including type 2 diabetes, metabolic syndrome, non-alcoholic fatty liver disease (NAFLD), or severe insulin resistance, who have tried semaglutide or tirzepatide without achieving adequate weight loss results, who have significant metabolic resistance meaning their physiology actively resists weight loss through compensatory hormonal mechanisms, who need the most potent available tool for weight reduction alongside lifestyle changes and medical supervision, or who are seeking to avoid bariatric surgery but need a comparable level of intervention
Whether this has clinical significance is unknown, but researchers who track their results closely often notice more consistent appetite suppression and energy levels when they maintain consistent injection sites
How long does BPC-157 stay in the body after stopping use? BPC-157 has a serum elimination half-life of 46 hours in animal models, suggesting 99% clearance within 30 hours
